Entries by Mediplus Pharma

Our Director’s Interview Featured in WWD BEAUTY JAPAN

In the August 26, 2024 issue of WWD BEAUTY(published by WWD JAPAN) an interview with our Director and Executive Fellow, Gotaro Shioda, was featured under the title “The Potential of ‘Ozonized Glycerin’ for Dramatic Skin Regeneration Without Side Effects” in the article “BEAUTY RESEARCHERS Vol.8”.

Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association

Mediplus Pharma, Inc. presented the safety and efficacy of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), in formulations for atopic dermatitis at the 123rd Annual Meeting of the Japanese Dermatological Association. The conference was held from June 6 to June 9, 2024, at the Kyoto International Conference Center. For more details on the press release, please visit here.https://prtimes.jp/main/html/rd/p/000000015.000079724.html

Presentation on Multifunctionality of Ozonized Glycerin (Novel Glycerin Compounds) and Their Application as Biomaterials at the World Biomaterials Congress

Mediplus Pharma, Inc. (CEO: Kenji Ito, HQ: Shibuya, Tokyo) presented on the multifunctionality and application of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), as biomaterials at the 12th World Biomaterials Congress (WBC), held over six days from May 26 to 31, 2024, in Daegu, South Korea. For more details on the press release, please visit here.https://prtimes.jp/main/html/rd/p/000000013.000079724.html

Announcement of Exhibition at the Institute for Predictable Osseointegration in Implantology Academic Conference

We are pleased to announce our participation in the 16th Academic Conference of the Non-Profit Organization (NPO) Institute for Predictable Osseointegration in Implantology, which will be held on Sunday, July 7, 2024, in Fukuoka City.We aim to introduce our unique ingredient , ozonized glycerin, which is expected to have beneficial effects in dental medicine, particularly in the surgical field. This […]

Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD

A presentation on the safety and efficacy evaluation of atopic dermatitis was held at the American Academy of Dermatology (AAD) in March, and it has been featured in the “Health Industry Distribution Newspaper” issue 1111 (published on 4/25). We plan to continue utilizing Novel Glycerin Compounds (ozonized glycerin) extensively in the business ventures undertaken by our group companies in the […]

Announcement of New Patent Information Page Launch

We are pleased to announce the launch of our new patent information page.PATENTThis page provides disclosures of the patent registration information that we possess. Interested parties are invited to explore this resource to better understand it further.

Antibiotic

It is a compound produced by microorganisms that has the effect of inhibiting the growth of other microorganisms and cells.

Methicillin

Methicillin is an antibiotic of the penicillin class. It is rarely used because it is unstable and difficult to handle in medical facilities.